Raymond James Financial Inc. Makes New Investment in U.S. Physical Therapy, Inc. (NYSE:USPH)
2025-04-25T09:00:56Z
Raymond James Financial Inc. acquired a new stake in U.S. Physical Therapy, Inc. (NYSE:USPH – Free Report) during the 4th quarter, HoldingsChannel.com reports. The institutional investor acquired 70,341 shares of the company’s stock, valued at approximately $…
Raymond James Financial Inc. acquired a new stake in U.S. Physical Therapy, Inc. (NYSE:USPH – Free Report) during the 4th quarter, HoldingsChannel.com reports. The institutional investor acquired 70,341 shares of the company’s stock, valued at approximately $6,240,000.
A number of other hedge funds have also modified their holdings of USPH. Renaissance Technologies LLC grew its position in U.S. Physical Therapy by 5.6% in the fourth quarter. Renaissance Technologies LLC now owns 91,923 shares of the company’s stock valued at $8,154,000 after acquiring an additional 4,900 shares during the period. Envestnet Asset Management Inc. grew its holdings in shares of U.S. Physical Therapy by 20.1% in the 4th quarter. Envestnet Asset Management Inc. now owns 299,791 shares of the company’s stock worth $26,594,000 after purchasing an additional 50,163 shares during the last quarter. Wells Fargo & Company MN increased its position in shares of U.S. Physical Therapy by 2.2% during the 4th quarter. Wells Fargo & Company MN now owns 112,959 shares of the company’s stock worth $10,021,000 after purchasing an additional 2,465 shares in the last quarter. ExodusPoint Capital Management LP lifted its holdings in U.S. Physical Therapy by 355.1% during the 4th quarter. ExodusPoint Capital Management LP now owns 26,413 shares of the company’s stock valued at $2,343,000 after purchasing an additional 20,609 shares during the last quarter. Finally, Level Four Advisory Services LLC boosted its position in U.S. Physical Therapy by 3.4% in the fourth quarter. Level Four Advisory Services LLC now owns 12,512 shares of the company’s stock valued at $1,110,000 after buying an additional 413 shares in the last quarter.
Get U.S. Physical Therapy alerts:
U.S. Physical Therapy Trading Up 1.1 %
Shares of USPH opened at $69.52 on Friday. The stock’s fifty day simple moving average is $74.98 and its 200-day simple moving average is $84.42. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.27. The firm has a market capitalization of $1.06 billion, a PE ratio of 73.96, a price-to-earnings-growth ratio of 3.54 and a beta of 1.38. U.S. Physical Therapy, Inc. has a 12-month low of $62.77 and a 12-month high of $108.14.
U.S. Physical Therapy Increases Dividend
U.S. Physical Therapy ( NYSE:USPH Get Free Report ) last issued its earnings results on Wednesday, February 26th. The company reported $0.65 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.69 by ($0.04). U.S. Physical Therapy had a net margin of 3.54% and a return on equity of 8.11%. The business had revenue of $180.45 million during the quarter, compared to the consensus estimate of $173.10 million. As a group, research analysts predict that U.S. Physical Therapy, Inc. will post 2.67 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which was paid on Friday, April 11th. Shareholders of record on Friday, March 14th were issued a dividend of $0.45 per share. This represents a $1.80 dividend on an annualized basis and a yield of 2.59%. The ex-dividend date was Friday, March 14th. This is a positive change from U.S. Physical Therapy’s previous quarterly dividend of $0.44. U.S. Physical Therapy’s payout ratio is currently 97.83%.
Analyst Ratings Changes
A number of research analysts have recently issued reports on the stock. Barrington Research cut their target price on shares of U.S. Physical Therapy from $108.00 to $98.00 and set an “outperform” rating for the company in a research note on Friday, February 28th. JMP Securities reissued a “market outperform” rating and issued a $113.00 price objective on shares of U.S. Physical Therapy in a research note on Tuesday. StockNews.com lowered U.S. Physical Therapy from a “hold” rating to a “sell” rating in a research note on Thursday, April 17th. JPMorgan Chase & Co. cut their price target on U.S. Physical Therapy from $120.00 to $110.00 and set an “overweight” rating for the company in a report on Wednesday, March 19th. Finally, William Blair reissued a “market perform” rating on shares of U.S. Physical Therapy in a report on Thursday, February 27th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, U.S. Physical Therapy currently has a consensus rating of “Moderate Buy” and an average price target of $109.00.
Check Out Our Latest Analysis on USPH
Insider Buying and Selling at U.S. Physical Therapy
In other news, COO Graham D. Reeve sold 1,730 shares of the business’s stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $82.11, for a total transaction of $142,050.30. Following the completion of the transaction, the chief operating officer now directly owns 7,168 shares in the company, valued at approximately $588,564.48. The trade was a 19.44 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 2.00% of the company’s stock.
U.S. Physical Therapy Profile
(Free Report)
U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
Featured Articles
Want to see what other hedge funds are holding USPH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for U.S. Physical Therapy, Inc. (NYSE:USPH – Free Report).
Receive News & Ratings for U.S. Physical Therapy Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for U.S. Physical Therapy and related companies with MarketBeat.com’s FREE daily email newsletter.
Auto-posted from news source
About The Author
